{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:50:52Z","timestamp":1790401852010,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.chest.2021.03.049","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T17:09:34Z","timestamp":1617296974000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD"],"prefix":"10.1016","volume":"160","author":[{"given":"Donald A.","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.G.","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.chest.2021.03.049_bib2","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1164\/rccm.201810-1895ST","article-title":"Current status and future opportunities in lung precision medicine research with a focus on biomarkers. An American Thoracic Society\/National Heart, Lung, and Blood Institute Research Statement","volume":"198","author":"Wu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2021.03.049_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chest.2017.05.020","article-title":"Precision medicine urgency: the case of inhaled corticosteroids in COPD","volume":"152","author":"Suissa","year":"2017","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2021.03.049_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.chest.2021.03.049_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.03.049_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2021.03.049_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.2009.113662","article-title":"Adherence to inhaled therapy, mortality and hospital admission in COPD","volume":"64","author":"Vestbo","year":"2009","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2021.03.049_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1164\/rccm.201712-2469LE","article-title":"The clinical impact of different adherence behaviors in patients with severe chronic obstructive pulmonary disease","volume":"197","author":"Cushen","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib10","first-page":"217","article-title":"Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation","volume":"4","author":"Sharma","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.chest.2021.03.049_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/1479973119901234","article-title":"Device use errors with soft mist inhalers: a global systematic literature review and meta-analysis","volume":"17","author":"Navaie","year":"2020","journal-title":"Chron Respir Dis"},{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib12","first-page":"267","article-title":"Inhalation technique errors with metered-dose inhalers among patients with obstructive lung diseases: a systematic review and meta-analysis of U.S. studies","volume":"6","author":"Cho-Reyes","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-017-0710-y","article-title":"Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes","volume":"19","author":"Usmani","year":"2018","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.chest.2021.03.049_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.rmed.2011.11.016","article-title":"Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use","volume":"106","author":"Melani","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2021.03.049_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/jamp.2017.1416","article-title":"Peak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalers","volume":"30","author":"Ghosh","year":"2017","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"7","key":"10.1016\/j.chest.2021.03.049_bib16","first-page":"1103","article-title":"Peak inspiratory flow rate as a criterion for dry powder inhaler use in chronic obstructive pulmonary disease","volume":"14","author":"Mahler","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2021.03.049_bib17","first-page":"9473051","article-title":"Matching inhaler devices with patients: the role of the primary care physician","volume":"2018","author":"Kaplan","year":"2018","journal-title":"Can Respir J"},{"issue":"6","key":"10.1016\/j.chest.2021.03.049_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1513\/pats.200904-019DS","article-title":"Biomarkers in chronic obstructive pulmonary disease","volume":"6","author":"Sin","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.chest.2021.03.049_bib19","doi-asserted-by":"crossref","first-page":"1495867","DOI":"10.1155\/2017\/1495867","article-title":"Guiding inspiratory flow: development of the In-Check DIAL G16, a tool for improving inhaler technique","volume":"2017","author":"Sanders","year":"2017","journal-title":"Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2021.03.049_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3132\/pcrj.2007.00017","article-title":"Inhalation therapy: an historical review","volume":"16","author":"Sanders","year":"2007","journal-title":"Prim Care Respir J"},{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/089426801316970268","article-title":"Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity","volume":"14","author":"Chodosh","year":"2001","journal-title":"J\u00a0Aerosol Med"},{"issue":"5","key":"10.1016\/j.chest.2021.03.049_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1183\/13993003\/erj.18.5.780","article-title":"Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers","volume":"18","author":"Broeders","year":"2001","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2021.03.049_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0954-6111(97)90009-3","article-title":"Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler","volume":"91","author":"Everard","year":"1997","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2021.03.049_bib24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00166410","article-title":"What the pulmonary specialist should know about the new inhalation therapies","volume":"37","author":"Laube","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1248\/bpb.30.162","article-title":"Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler","volume":"30","author":"Yokoyama","year":"2007","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0954-6111(98)90040-3","article-title":"A\u00a0comparison of the performance of two modern multidose dry powder asthma inhalers","volume":"92","author":"Hill","year":"1998","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2021.03.049_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/10837450.2011.620970","article-title":"Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow","volume":"18","author":"Abdelrahim","year":"2013","journal-title":"Pharm Dev Technol"},{"issue":"6","key":"10.1016\/j.chest.2021.03.049_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/jamp.2015.1223","article-title":"The ELLIPTA(R) dry powder inhaler: design, functionality, in\u00a0vitro dosing performance and critical task compliance by patients and caregivers","volume":"28","author":"Grant","year":"2015","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"6","key":"10.1016\/j.chest.2021.03.049_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/jamp.2019.1584","article-title":"Wixela Inhub: dosing performance in\u00a0vitro and inhaled flow rates in healthy subjects and patients compared with Advair Diskus","volume":"33","author":"Cooper","year":"2020","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.chest.2021.03.049_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rmed.2016.07.013","article-title":"Inhalation device requirements for patients\u2019 inhalation maneuvers","volume":"118","author":"Haidl","year":"2016","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2021.03.049_bib31","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1183\/09031936.00024807","article-title":"Inspiratory flow rates at different levels of resistance in elderly COPD patients","volume":"31","author":"Janssens","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.03.049_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/2193-1801-3-496","article-title":"Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus Inhaler and baseline spirometric parameters: a cross-sectional study","volume":"3","author":"Seheult","year":"2014","journal-title":"SpringerPlus"},{"key":"10.1016\/j.chest.2021.03.049_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/COPD.S11474","article-title":"Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters","volume":"5","author":"Malmberg","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2021.03.049_bib35","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2147\/COPD.S174371","article-title":"Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation","volume":"13","author":"Price","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2021.03.049_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/COPD.S195438","article-title":"Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD","volume":"14","author":"Ghosh","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib37","first-page":"246","article-title":"Spirometry measurement of peak inspiratory flow identifies suboptimal use of dry powder inhalers in ambulatory patients with COPD","volume":"6","author":"Duarte","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.chest.2021.03.049_bib38","doi-asserted-by":"crossref","first-page":"105298","DOI":"10.1016\/j.ejps.2020.105298","article-title":"Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients","volume":"147","author":"Harb","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.chest.2021.03.049_bib39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.chest.2020.03.072","article-title":"Peak inspiratory flows: defining repeatability limits and a predictive equation for different inhalers","volume":"158","author":"Barnes","year":"2020","journal-title":"Chest"},{"issue":"suppl A","key":"10.1016\/j.chest.2021.03.049_bib40","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.rmed.2004.02.003","article-title":"Pressure and inspiratory flow characteristics of dry powder inhalers","volume":"98","author":"Cegla","year":"2004","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2021.03.049_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jamp.2012.0987","article-title":"Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus(R) dry powder inhaler","volume":"26","author":"Mahler","year":"2013","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.chest.2021.03.049_bib42","doi-asserted-by":"crossref","first-page":"105857","DOI":"10.1016\/j.rmed.2019.105857","article-title":"The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease","volume":"161","author":"Mahler","year":"2020","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.chest.2021.03.049_bib43","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.rmed.2007.06.008","article-title":"Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?","volume":"101","author":"Al-Showair","year":"2007","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.chest.2021.03.049_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.rmed.2004.04.010","article-title":"The course of inhalation profiles during an exacerbation of obstructive lung disease","volume":"98","author":"Broeders","year":"2004","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1183\/09031936.94.07010069","article-title":"Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects","volume":"7","author":"Borgstr\u00f6m","year":"1994","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2021.03.049_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/jamp.2013.1038","article-title":"Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate","volume":"27","author":"Mahler","year":"2014","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"10.1016\/j.chest.2021.03.049_bib47","first-page":"321","article-title":"Nebulized versus dry powder long-acting muscarinic antagonist bronchodilators in patients with COPD and suboptimal peak inspiratory flow rate","volume":"6","author":"Mahler","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"8","key":"10.1016\/j.chest.2021.03.049_bib48","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1513\/AnnalsATS.201611-903OC","article-title":"Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions","volume":"14","author":"Loh","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2021.03.049_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227737","article-title":"Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"15","author":"Samarghandi","year":"2020","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.chest.2021.03.049_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020718","article-title":"Inhaler device feature preferences among patients with obstructive lung diseases: a systematic review and meta-analysis","volume":"99","author":"Navaie","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.chest.2021.03.049_bib51","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","article-title":"Pharmacologic management of chronic obstructive pulmonary disease. An Official American Thoracic Society clinical practice guideline","volume":"201","author":"Nici","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2021.03.049_bib52","doi-asserted-by":"crossref","first-page":"1801147","DOI":"10.1183\/13993003.01147-2018","article-title":"Digital technologies and adherence in respiratory diseases: the road ahead","volume":"52","author":"Blakey","year":"2018","journal-title":"Eur Respir J"},{"issue":"suppl 63","key":"10.1016\/j.chest.2021.03.049_bib53","first-page":"PA4258","article-title":"Real-life inhaler technique in asthma patients using the electronic ProAir Digihaler","volume":"54","author":"Chrystyn","year":"2019","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2021.03.049_bib54","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A\u00a0new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221006620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221006620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:34:15Z","timestamp":1757925255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221006620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0012369221006620"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.03.049","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}